In this study, a high expression of EPHA4 in glioma cells was found to potentiate FGF2–FGFR1 signaling and promoted cell growth and migration through the AKT/MAPK and RAC1/CDC42 pathways, respectively. This evidence concerns the gene EPHA4 and glioma.